Navigation Links
Increased Investments in New Drug Development Drives Demand for Cell-Based Assays, According to an Upcoming Report by Global Industry Analysts, Inc.
Date:7/17/2014

San Jose, California (PRWEB) July 17, 2014

Follow us on LinkedIn – GIA is pleased to announce the launch of a major research program analysing the trends impacting the market for “Cell-Based Assays”. Invited to participate in this comprehensive grassroots level global research initiative are senior industry executives, domain experts, technologists and market strategists. The new report to be issued shortly will offer accurate assessment of global market developments including major technologies, trends and challenges, together with descriptive, exploratory, and quantitative analysis of major product and geographic market segments. For details about how you can participate in this primary research program to include your inputs prior to the publication, please click here.

The drug discovery sector is the major end-user of cell-based assays. Characterized by versatility, cell-based assays represent a powerful research tool that provides valuable information for successful R&D. Cell-based assays also facilitate in studying biological characteristics of target drug compounds and their impact on cells/cellular systems in terms of activation of cell receptors, alteration in gene activity and expression of proteins. These assays are therefore emerging as a preferred tool for screening potential drug molecules. Cell-based assays also play an important role in toxicology testing in early stages of drug discovery, thereby reducing overall costs and the risk of clinical trial failures. Additionally, the market is being driven by the availability of high throughput screening (HTS) systems and advanced technological innovations such as development of label-free cell-based assays. Growing focus on expansion of drug portfolios and the ensuing increased investments in new drug development by pharma majors will generate lucrative opportunities for growth in the coming years.

The upcoming report will offer coverage on major companies including BD Biosciences, Beckman Coulter Inc., EMD Millipore, GE Healthcare Life Sciences, Life Technologies Corp, and Qiagen NV, among others.

In addition, the study will also provide:

  •     Valuable market based intelligence on new emerging trends, growth drivers, issues and challenges.
  •     Current coverage on company information and latest news and events including strategic corporate developments, and product innovations
  •     Fresh research perspectives, statistical findings, analyst analysis, and commentaries
  •     Accurate market estimates, projections, and forecasts across major market segments (Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation) and geographic regions (the United States, Japan, Europe, and Rest of World).

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/cell_based_assays_market/healthcare_industry/prweb12026138.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Hospital-Diagnosed Maternal Infections Linked to Increased Autism Risk
2. New Genedata Expressionist for Mass Spectrometry Gains Increased Adoption in Metabolomics R&D
3. Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
4. SoundConnect Responds to Increased, Cost-Effective Unified Communications Demands Through Agent Partnership Program
5. Physician Familiarity With Biosimilars Has Increased Significantly Over The Past Year
6. High-flying pilots at increased risk of brain lesions
7. Pipette.com, Major Liquid Handling Distributor, Has Increased Their Bottletop Dispenser Stock
8. Kitware to Develop an In Situ Cosmology Analysis Framework for Increased Understanding of the Universe
9. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
10. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
11. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
Breaking Biology News(10 mins):